Cargando…
Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512917/ https://www.ncbi.nlm.nih.gov/pubmed/36163461 http://dx.doi.org/10.1038/s41598-022-20899-w |
| _version_ | 1784797938034147328 |
|---|---|
| author | AlQahtani, Manaf Kumar, Nitya Aljawder, Dhuha Abdulrahman, Abdulkarim Mohamed, Mohammed Wael Alnashaba, Fatema Fayyad, Mohammed Abu Alshaikh, Faisal Alsahaf, Fatima Saeed, Sawsan Almahroos, Amal Abdulrahim, Zainab Otoom, Sameer Atkin, Stephen L. |
| author_facet | AlQahtani, Manaf Kumar, Nitya Aljawder, Dhuha Abdulrahman, Abdulkarim Mohamed, Mohammed Wael Alnashaba, Fatema Fayyad, Mohammed Abu Alshaikh, Faisal Alsahaf, Fatima Saeed, Sawsan Almahroos, Amal Abdulrahim, Zainab Otoom, Sameer Atkin, Stephen L. |
| author_sort | AlQahtani, Manaf |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9512917 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95129172022-09-27 Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease AlQahtani, Manaf Kumar, Nitya Aljawder, Dhuha Abdulrahman, Abdulkarim Mohamed, Mohammed Wael Alnashaba, Fatema Fayyad, Mohammed Abu Alshaikh, Faisal Alsahaf, Fatima Saeed, Sawsan Almahroos, Amal Abdulrahim, Zainab Otoom, Sameer Atkin, Stephen L. Sci Rep Author Correction Nature Publishing Group UK 2022-09-26 /pmc/articles/PMC9512917/ /pubmed/36163461 http://dx.doi.org/10.1038/s41598-022-20899-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction AlQahtani, Manaf Kumar, Nitya Aljawder, Dhuha Abdulrahman, Abdulkarim Mohamed, Mohammed Wael Alnashaba, Fatema Fayyad, Mohammed Abu Alshaikh, Faisal Alsahaf, Fatima Saeed, Sawsan Almahroos, Amal Abdulrahim, Zainab Otoom, Sameer Atkin, Stephen L. Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease |
| title | Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease |
| title_full | Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease |
| title_fullStr | Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease |
| title_full_unstemmed | Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease |
| title_short | Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease |
| title_sort | author correction: randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate covid-19 disease |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512917/ https://www.ncbi.nlm.nih.gov/pubmed/36163461 http://dx.doi.org/10.1038/s41598-022-20899-w |
| work_keys_str_mv | AT alqahtanimanaf authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT kumarnitya authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT aljawderdhuha authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT abdulrahmanabdulkarim authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT mohamedmohammedwael authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT alnashabafatema authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT fayyadmohammedabu authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT alshaikhfaisal authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT alsahaffatima authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT saeedsawsan authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT almahroosamal authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT abdulrahimzainab authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT otoomsameer authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease AT atkinstephenl authorcorrectionrandomizedcontrolledtrialoffavipiravirhydroxychloroquineandstandardcareinpatientswithmildmoderatecovid19disease |